Kura Oncology Inc (KURA) — Capital Reinvestment Ratio

Latest as of December 2025: 0.02x

Kura Oncology Inc (KURA) has a Capital Reinvestment Ratio of 0.02x as of December 2025, meaning it reinvests 0% of its operating cash flow ($117.27 Million) in capital expenditures ($2.32 Million). See KURA equity financing ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.02x

Capex / Operating Cash Flow

Operating Cash Flow

$117.27 Million

USD

Capital Expenditures

$2.32 Million

USD

Data as of

Dec 2025

Most recent filing

Kura Oncology Inc Capital Reinvestment Ratio (2024–2024)

This chart tracks Kura Oncology Inc's Capital Reinvestment Ratio across 1 annual periods. Check Kura Oncology Inc (KURA) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Kura Oncology Inc (2024–2024)

Year-by-year Capital Reinvestment Ratio for Kura Oncology Inc from 2024 to 2024. For live market cap and broader valuation context, see KURA stock market capitalisation.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change
2024	0.00x	$134.32 Million	$472.00K	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow